ASSET | DATE | % RETURN |
---|---|---|
GreenPro Capital (GRNQ) | 7/2/2015 - 8/6/2015 | 1,042.86% |
Netcapital (NCPL) | 7/2/2015 - 8/6/2015 | 250% |
Anavex Life Sciences (AVXL) | 7/2/2015 - 8/6/2015 | 222.22% |
ProMIS Neurosciences (PMN) | 7/2/2015 - 8/6/2015 | 200% |
Rocket Pharmaceuticals (RCKT) | 7/2/2015 - 8/6/2015 | 181.8% |
Biovie (BIVI) | 7/2/2015 - 8/6/2015 | 171.43% |
CEA Industries (CEAD) | 7/2/2015 - 8/6/2015 | 171.11% |
Oragenics (OGEN) | 7/2/2015 - 8/6/2015 | 131.11% |
Verb Technology (VERB) | 7/2/2015 - 8/6/2015 | 130.77% |
Protagenic Therapeutics (PTIX) | 7/2/2015 - 8/6/2015 | 100% |
authID (AUID) | 7/2/2015 - 8/6/2015 | 100% |
Xenetic Biosciences (XBIO) | 7/2/2015 - 8/6/2015 | 81.82% |
TVRD (TVRD) | 7/2/2015 - 8/6/2015 | 75.46% |
Exelixis (EXEL) | 7/2/2015 - 8/6/2015 | 69.25% |
Beam Global (BEEM) | 7/2/2015 - 8/6/2015 | 65.14% |
Ambow Education (AMBO) | 7/2/2015 - 8/6/2015 | 60% |
LifeMD (LFMD) | 7/2/2015 - 8/6/2015 | 55.56% |
Intergroup (INTG) | 7/2/2015 - 8/6/2015 | 53.01% |
VerifyMe (VRME) | 7/2/2015 - 8/6/2015 | 51.86% |
CleanSpark (CLSK) | 7/2/2015 - 8/6/2015 | 50% |
Lexicon Pharmaceuticals (LXRX) | 7/2/2015 - 8/6/2015 | 50% |
Renovaro Biosciences (RENB) | 7/2/2015 - 8/6/2015 | 49.5% |
Optex Systems Holdings, Inc Common Stock (OPXS) | 7/2/2015 - 8/6/2015 | 48.33% |
Predictive Oncology (POAI) | 7/2/2015 - 8/6/2015 | 48.28% |
US Energy (USEG) | 7/2/2015 - 8/6/2015 | 46.75% |